IDiyas

For the Inventor, By the Inventor

Haddonfield, NJ, United States of America

Lawrence I Kruse

USPTO Granted Patents = 45

 

Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 297(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1984)
  • Hertfordshire, GB (1989)
  • Tewin, GB (1988 - 1990)
  • Malvern, PA (US) (1992 - 1993)
  • Haddonfield, NJ (US) (1983 - 2007)

Company Filing History:

goldMedal28 out of 207 
 
Smithkline Beckman Corporation
 patents
silverMedal10 out of 69 
 
Adolor Corporation
 patents
bronzeMedal2 out of 2,198 
 
Smithkline Beecham Corporation
 patents
4. 1 out of 1,061 
 
Sanshin Kogyo Kabushiki Kaisha
 patents
5. 1 out of 5 
 
Sanofi Pharmaceuticals, Inc.
 patents
6. 1 out of 1 
 
Smithklein Beckman Corporation
 patent
7. 1 out of 12 
 
Symphar S.a.
 patents
8. 1 out of 362 
 
Smith Kline & French Laboratories Limited
 patents

Years Active: 1983-2007

Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents
1. 7294647 - Kappa agonist compounds and pharmaceutical formulations thereof (2007-11-13),
2. 6960612 - Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2005-11-01),
3. 6180623 - Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2001-01-30),
4. 6028063 - Kappa agonist compounds, pharmaceutical formulations and method of (2000-02-22),
5. 5981513 - Kappa agonist compounds, pharmaceutical formulations and method of (1999-11-09),
6. 5945443 - Kappa agonist compounds and pharmaceutical formulations thereof (1999-08-31),
7. 5872207 - N-terminal-marked peptides immobilized on glass beads and method of (1999-02-16),
8. 5763445 - Kappa agonist compounds pharmaceutical formulations and method of (1998-06-09),
9. 5744458 - Kappa agonist compounds and pharmaceutical formulations thereof (1998-04-28),
10. 5688955 - Kappa agonist compounds and pharmaceutical formulations thereof (1997-11-18),
11. 5646151 - Kappa agonist compounds and pharmaceutical formulations thereof (1997-07-08),
12. 5571833 - Tryptamine analogues, their synthesis and their use as 5-HT.sub.1 -like (1996-11-05),
13. 5204336 - Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted (1993-04-20),
14. 5147875 - 2-(substituted phenyl)-4-oxo-quinazolines (1992-09-15),
15. 4992459 - Dopamine-.beta.-hydroxylase inhibitors (1991-02-12),

Title: The Innovative Journey of Lawrence I Kruse

Introduction: Lawrence I Kruse, a distinguished inventor hailing from Haddonfield, NJ (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: Lawrence I Kruse holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: With a career spanning over two decades, Lawrence I Kruse has established himself as a visionary inventor known for his ability to transform ideas into tangible solutions. He has worked with leading companies to develop cutting-edge products that have revolutionized their respective markets.

Collaborations: Throughout his career, Lawrence I Kruse has collaborated with top researchers, engineers, and designers to bring his inventions to life. His collaborative approach has led to the successful commercialization of several innovative products that have had a lasting impact on society.

Conclusion: Lawrence I Kruse's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions. His dedication to pushing the boundaries of what is possible continues to inspire the next generation of inventors to dream big and create a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…